Jazz Pharmaceuticals

Jazz's 2025 sustainability report says the company introduced MOMENTUM in 2025, a clinical trial toolbox for patient-representation insights. It says MOMENTUM draws on large language model technology to help teams design more representative trials and recruit patient populations that reflect true disease epidemiology.

Jazz's 2025 sustainability report says that in 2025 the company formally established an AI Council for cross-functional governance and oversight of AI use, and that it established AI Responsible Use Guidelines to define expectations and support consistent application.

Jazz's 2025 sustainability report says that in the fourth quarter of 2025 the company launched an enterprise-wide AI Literacy platform to build foundational capability across the workforce.